BMT CTN Protocol 0101 -- A Randomized Double-blind Trial of Fluconazole vs. Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Recipients

Below are protocol-related doucments, which may be periodically updated.

• Protocol synopsis, Version 7.0 dated March 29, 2006
• Protocol, Version 7.0 dated March 29, 2006
• Protocol amendment (summary of changes from Version 6.0 to 7.0)
• Consent forms, Version 7.0 dated March 29, 2006
• Participating Centers
• Frequently Asked Questions
• Educational Materials
• Participant Brochure
• Key Personnel

  Protocol Chair:  John Wingard, MD (352-273-8021) wingajr@medicine.ufl.edu

  Protocol Officer:  Dennis Confer, MD (612-362-3425) dconfer@nmdp.org

  Protocol Coordinator:  Iris Gersten, MS (301-251-1161) igersten@emmes.com

  Medical Monitor:  Marcelo Pasquini, MD (414-805-0700)  mpasquin@mcw.edu

This study reached projected accrual on September 21, 2006 and is now closed to new patients.